Tickers

1. Composite Trajectory Verdict

Given WDAY's subscription-based SaaS model, the income statement (revenue growth, margin expansion) and cash flow statement (operating cash flow and free cash flow generation) carry the most weight for assessing financial performance, while the balance sheet primarily reflects capital allocation decisions (share repurchases, acquisitions) funded by that cash generation.

Composite Trajectory: Improving

The improving call is driven by consistent double-digit revenue growth (13% YoY for FY2026 and Q2 FY2027), expanding GAAP operating margins (7.5% for FY2026 vs 4.9% for FY2025; 11.8% for Q2 FY2027 vs 10.6% for Q2 FY2026), and rising operating cash flows (+19% YoY for FY2026; +13% YoY for six months ended July 2026). Free cash flow also grew strongly (+27% YoY for FY2026; +7% YoY for six months). The balance sheet shows a mixed picture: cash and investments declined sharply due to $2.9B in share repurchases during FY2026 and a further $2.9B in the first half of FY2027, and goodwill rose 50% from acquisitions, but unearned revenue (backlog) grew 12% annually and 8% quarterly, and the company maintains a $1.0B undrawn revolver.

2. Red Flags

• Aggressive capital return draining cash: Cash, cash equivalents, and marketable securities fell 32% annually (from $8,017M to $5,443M) and 37% in six months (to $3,403M) primarily due to $2.9B of share repurchases in FY2026 and $2.9B in the first half of FY2027 (10-K 2026-01-31, Consolidated Statements of Cash Flows; 10-Q 2026-07-31, Consolidated Statements of Cash Flows).
• Goodwill surge from acquisitions: Goodwill increased 50% to $5,229M (from $3,478M) in FY2026 following the Paradox ($1.1B) and Sana ($1.1B) acquisitions, creating integration risk and potential future impairment exposure (10-K 2026-01-31, Consolidated Balance Sheets; Note 7).
• Recurring restructuring charges: Restructuring expenses of $303M in FY2026 (Fiscal 2026 Plan) and $135M in Q2 FY2027 (Fiscal 2027 Plan) appear in consecutive periods, totaling $438M over ~18 months (10-K 2026-01-31, Note 21; 10-Q 2026-07-31, MD&A Restructuring).
• Large non-recurring tax benefit distorting net income trend: FY2024 net income of $1,381M included a $1,025M tax benefit; FY2025 net income was $526M; FY2026 net income was $693M. The FY2027 Q2 net income of $632M included a $374M deferred tax asset benefit from an intra-entity IP transfer (10-K 2026-01-31, Consolidated Statements of Operations; 10-Q 2026-07-31, Provision For Income Taxes).
• Valuation allowance on deferred tax assets growing: Valuation allowance increased to $1.433B (from $1.259B) in FY2026, primarily related to state tax credits, foreign intangibles, and foreign net operating losses (10-K 2026-01-31, Note 17).
• Other income decline: Other income, net dropped to $14M in Q2 FY2027 from $56M in Q2 FY2026 due to liquidation of marketable debt securities to fund acquisitions and repurchases (10-Q 2026-07-31, Other Income, Net).

3. Earnings Assessment (Income Statement)

Earnings Trajectory: Improving

Total revenue grew 13% YoY to $9.552B in FY2026 (vs $8.446B in FY2025) and 13% YoY to $2.649B in Q2 FY2027 (vs $2.348B in Q2 FY2026) (10-K 2026-01-31, Consolidated Statements of Operations; 10-Q 2026-07-31, Consolidated Statements of Operations). Subscription services revenue, ~92-93% of total, grew 14% annually and 14% quarterly. GAAP operating income rose 74% annually to $721M (margin 7.5% vs 4.9%) and 26% quarterly to $313M (margin 11.8% vs 10.6%). Net income increased 32% annually to $693M and 177% quarterly to $632M (though Q2 FY2027 benefited from a $374M tax benefit). Gross revenue retention remained ~97%. Total subscription revenue backlog grew 12% annually to $28.1B and 8% quarterly to $27.4B (10-K 2026-01-31, MD&A; 10-Q 2026-07-31, MD&A).

4. Cash Generation Assessment (Statement of Cash Flows)

Cash Trajectory: Improving

Net cash provided by operating activities increased 19% YoY to $2.939B in FY2026 (vs $2.461B in FY2025) and 13% YoY to $1.215B for the six months ended July 2026 (vs $1.073B) (10-K 2026-01-31, Consolidated Statements of Cash Flows; 10-Q 2026-07-31, Consolidated Statements of Cash Flows). Free cash flow (operating cash flow less capex) grew 27% annually to $2.777B and 7% for the six-month period to $1.076B. The improvement was driven by higher cash collections from increased sales, partially offset by higher supplier and employee payments. Capital expenditures were $162M in FY2026 and $139M for six months ended July 2026, with FY2027 capex guided at ~$270M (10-K 2026-01-31, Liquidity; 10-Q 2026-07-31, Liquidity).

5. Balance Sheet Assessment

Balance Sheet Trajectory: Mixed

Cash, cash equivalents, and marketable securities declined 32% annually to $5.443B (from $8.017B) and 37% in six months to $3.403B, driven by $2.9B of share repurchases in FY2026 and $2.9B in the first half of FY2027, plus $2.1B of acquisitions in FY2026 (10-K 2026-01-31, Consolidated Balance Sheets; 10-Q 2026-07-31, Consolidated Balance Sheets). Total assets were roughly flat annually ($18.074B vs $17.977B) but fell 12% in six months to $15.857B. Total liabilities rose 15% annually to $10.269B (from $8.943B) but fell 8% in six months to $9.397B due to reclassification of the 2027 Notes ($1.0B) to current. Stockholders' equity fell 14% annually to $7.805B and 17% in six months to $6.460B, mainly from treasury stock increasing to $7.151B (from $4.220B at Jan 2026). Unearned revenue (deferred revenue) grew 12% annually to $5.081B and the 12-month backlog grew 14% quarterly to $9.034B. Debt remained constant at $3.0B principal with a $1.0B undrawn revolver. The mixed assessment reflects strong liability generation (backlog) and liquidity adequacy offset by aggressive equity reduction via buybacks and goodwill inflation from acquisitions.

6. Data Gaps

• Quarterly (three-month) income statement and cash flow trends for Q1 FY2027, Q3 FY2026, and Q4 FY2026 (only Q2 FY2027 and six-month YTD are directly provided in the 10-Q 2026-07-31; the 10-Qs for 2026-04-30, 2025-10-31, and 2025-07-31 are listed but their detailed financial statement content is truncated in the provided materials).
• Standalone quarterly free cash flow for Q2 FY2027 (only six-month FCF is provided in the 10-Q 2026-07-31).
• Detailed breakdown of acquisition-related integration costs and revenue synergies for Paradox and Sana.
• Segment-level profitability (company operates as a single segment).
• Customer concentration metrics beyond "no customer >10% of revenue/receivables".
• Full contractual obligation schedule beyond the summary in the 10-K (Note 13).